Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishen Daluo Yin is a multi-herb traditional Chinese medicine (TCM) decoction/formula designed as a **combination therapy**. Its main reported uses are in the management of neurological and autoimmune diseases, most notably **multiple sclerosis** (MS). Its primary active components, identified through network pharmacology, include **quercetin** and **kaempferol**. Mechanistically, Yishen Daluo Yin exerts neuroprotective, anti-inflammatory, and immunomodulatory effects. It modulates several signaling pathways—such as **MAPK**, **AGE-RAGE**, **IL-17 signaling**, and neuroactive ligand-receptor interactions—targets inflammation, oxidative stress, cellular apoptosis, and regulates neuronal death and microglial activity. It exhibits a multi-target, multi-pathway mode of action typical for complex TCM decoctions[8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yishen Daluo Yin.